Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Media

The FT, Sky News, Bloomberg, WSJ, along with over 77 other leading press organisations worldwide quote our data and insight and consider us a trusted, independent source.

Preventative treatment of chronic migraine will continue to evolve in short-term with anti-CGRP mAbs effectiveness, says GlobalData

OnabotulinumtoxinA (BoNT-A) and monoclonal antibodies against the calcitonin gene-related protein (anti-CGRP mAbs) have emerged as the first disease-specific preventative treatments to be approved for chronic migraine. At the 10th Congress of the European Academy of Neurology (EAN) 2024, Danilo Antonio Montisano, MD, presented real-world evidence findings from a retrospective, observational multicenter cohort study (RAMO) comparing […]
Read more

Precision medicine transforms healthcare beyond oncology, says GlobalData

Precision medicine is reshaping healthcare beyond its traditional focus on oncology. This innovative approach tailors medical treatments to individual genetic, environmental, and lifestyle factors, enhancing disease prevention, diagnosis, and treatment efficacy. From reproductive health advancements like biomarker screenings in IVF to pandemic preparedness initiatives, precision medicine is expanding its impact across diverse medical fields, promising […]
Read more

AI-augmented robotics to elevate Industry 4.0, says GlobalData

The integration of advanced robotics and artificial intelligence (AI) is transforming several industries such as manufacturing, healthcare, automotive, and aerospace and forging a path towards the realization of Industry 4.0. While companies are heavily investing in proprietary technologies for innovation and productivity, challenges like cybersecurity and high costs remain. Collaborative R&D efforts and standardized policies […]
Read more

Total prevalent cases of female infertility to decrease at 0.4% AGR in 7MM during 2023-33, forecasts GlobalData

The total prevalent cases of female infertility in the seven major markets (*7MM) are projected to decrease from 16,732,165 cases in 2023 to 16,053,363 cases in 2033, registering a negative annual growth rate (AGR) of 0.41%, forecasts GlobalData, a leading data and analytics company. GlobalData’s latest report, “Female Infertility – Epidemiology Analysis and Forecast to […]
Read more

EMA approval of Sanofi/Regeneron’s Dupixent fills biologic gap in COPD, says GlobalData

Following the European Medicines Agency (EMA) approval of Sanofi/Regeneron’s Dupixent (Dupilumab) on 03 July 2024: Asiyah Nawab, Pharma Analyst at GlobalData, a leading data and analytics company, offers her view: “Dupixent, a monoclonal antibody (mAb) targeting interleukin-4 (IL4) and interleukin-13 (IL13) pathways, has been approved by the EMA as the first biologic for uncontrolled chronic […]
Read more

Eli Lilly’s Kisunla approval to heat up competition in the Alzheimer’s market, says GlobalData

Following the news that the FDA has approved Eli Lilly’s anti-amyloid beta (Aβ) monoclonal antibody (mAb) Kisunla (donanemab) for the treatment of patients with mild cognitive impairment (MCI) or mild Alzheimer’s disease (AD); Philippa Salter, Managing Neurology Analyst at GlobalData, a leading data and analytics company, offers her view: “After facing several delays, Lilly’s Kisunla […]
Read more

Boston Scientific’s DBS software signals positive shift in Parkinson’s disease treatment with CE marking, says GlobalData

Boston Scientific recently secured the European CE marking of its Vercise Neural Navigator 5 Software, a key component of the company’s Deep Brain Stimulation (DBS) system for Parkinson’s disease treatment. The rapid expansion and innovation in digital health technologies, coupled with developments like Boston Scientific’s new DBS system, signals a positive shift in patient care. […]
Read more

Companion diagnostics drive precision oncology growth and accessibility, says GlobalData

Companion diagnostic (CDx) tests play a pivotal role in modern oncology by identifying specific biomarkers that guide personalized cancer treatments. These tests, such as HER2 testing in breast cancer, determine eligibility for targeted therapies like trastuzumab. The evolving landscape of CDx tests is marked by decreasing costs, driven by technological advancements and economies of scale, […]
Read more

Poland defense expenditure to reach $48.5 billion in 2029, forecasts GlobalData

Poland seeks to strengthen its military readiness and contribute more to the North Atlantic Treaty Organization (NATO) following Russia’s illegal invasion of Ukraine and mounting concern over the future of transatlantic security cooperation. Seeking to deter an emboldened autocracy in Russia, Poland will increase defense spending from $36.4 billion in 2024 to $48.5 billion in […]
Read more

Direct-to-watch integration to strengthen Dexcom’s position in wearable health technology, says GlobalData

The COVID-19 pandemic has acted as a catalyst for the rapid implementation and development of wearable technology in the medical market. Wearable technologies, such as smartwatches and medical-grade wearables, have emerged as indispensable tools for remotely tracking glucose levels and managing diabetes. Following the wearable trend in medical, the recent update enables Apple Watch users […]
Read more
1 … 127 128 129 130 131 … 776